It is well recognized that the proliferation of vascular smooth muscle cells (VSMCs) is a key event in the pathogenesis of various vascular diseases, including atherosclerosis and hypertension. We have previously shown that among extracellular signal-regulated protein kinases (ERKs), the 42- and 44-kDa isoforms (ERK1/2) participate in the cellular mitogenic machinery triggered by several VSMCs activators, including insulin (INS) and thrombin (Thr). However, understanding of the intracellular signal transduction pathways involved is incomplete. This review considers the recent findings in INS and Thr signaling mechanisms that modulate the proliferation of VSMCs with particular emphasis on the ERK1/2 signaling pathway, an important mediator of VSMCs hypertrophy and vascular disease. Moreover, because the ERK1/2 pathway have been acknowledged as an important mediator of VSMCs hypertrophy, ERK1/2 is identified as a key target for novel therapeutic interventions to minimize irreversible tissue damage associated with hypertension and atherosclerosis.
Mulvany MJ, Hansen OK, Aalkjaer C.Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res. 1978;43(6):854-864.
2.
Folkow B.Physiological aspects of primary hypertension. Physiol Rev . 1982;62(2):347-504.
3.
Beckman JA, Creager MA, Libby P.Diabetes and atherosclerosis: epidemiology, pathophysiology, and management . JAMA. 2002; 287(19):2570-2581.
4.
Doran AC, Meller N., McNamara CARole of smooth muscle cells in the initiation and early progression of atherosclerosis . Arterioscler Thromb Vasc Biol. 2008;28(5):812-819.
5.
Hayashi K., Naiki T.Adaptation and remodeling of vascular wall; biomechanical response to hypertension . J Mech Behav Biomed Mater.2009;2(1):3-19.
6.
Mnjoyan ZH, Doan D., Brandon JL, et al. The critical role of the intrinsic VSMC proliferation and death programs in injury-induced neointimal hyperplasia. Am J Physiol . 2008;294(5): H2276-H2284.
7.
Sata M.Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation. Trends Cardiovasc Med. 2003;13(6):249-253.
8.
Ross R.The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362(6423):801-809.
9.
Campbell JH, Black MJ, Campbell GRReplication of smooth muscle vessel cells in atherosclerosis and hypertension . In: Meyer P, Marche P, eds. Blood Cells and Arteries in Hypertension and Atherosclerosis. New York: Raven Press; 1989:15-33.
10.
Pyorala M., Miettinen H., Halonen P., et al. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol. 2000;20(2):538-544.
11.
Sowers JR, Epstein M.Diabetes mellitus and associated hypertension, vascular disease, and nephropathy . An update. Hypertension. 1995;26(6 pt 1):869-879.
12.
Colwell JA, Jokl R.Vascular thrombosis in diabetes. In: Porte D, Sherwin R, Rifkin H, eds. Diabetes Mellitus: Theory and Practice. Norwalk, CT: Appleton and Lange;1996:207-216.
13.
Colwell JA, Lyons TJ, Klein RL, et al. Atherosclerosis and thrombosis in diabetes mellitus: new aspects of pathogenesis. In: Bowker JH, Pfeifer MA, eds. Levin and O’Neil’s: The Diabetic Foot. Philadelphia, PA: Mosby; 2001:65-106.
14.
Stout RWInsulin and atherogenesis. Eur J Epidemiol. 1992; 8(suppl 1):134-135.
15.
Avena R., Mitchell ME, Neville RF, et al. The additive effects of glucose and insulin on the proliferation of infragenicular vascular smooth muscle cells. J Vasc Surg . 1998;28(6):1033-1038.
Isenovic ER , Fretaud M., Koricanac G., et al. Insulin regulation of proliferation involves activation of Akt and Erk1/2 signaling pathways in vascular smooth muscle cells. Exp Clin Endocrinol Diabetes. 2009;117(5):214-219.
18.
Isenovic ER , Fretaud M., Dobutovic B., et al. A novel hypothesis regarding the possible involvement of cytosolic phospholipase 2 in insulin-stimulated proliferation of vascular smooth muscle cells. Cell Biol Int.2009;33(3):386-392.
19.
Fukuda N., Satoh C., Hu WY, et al. Endogenous angiotensin II suppresses insulin signaling in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens. 2001;19(9):1651-1658.
20.
McNamara CA , Sarembock IJ, Gimple LW, et al. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest. 1993;91(1):94-98.
21.
Glusa E.Vascular effects of thrombin. Semin Thromb Hemost. 1992;18(3):296-304.
22.
Hsieh HL, Tung WH, Wu CY, et al. Thrombin induces EGF receptor expression and cell proliferation via a PKC(δ)/c-Src- dependent pathway in vascular smooth muscle cells . Arterioscler Thromb Vasc Biol.2009;29(10):1594-1601.
23.
Kalmes A., Gunter D., Clowes WAEGFR transactivation in the regulation of SMC function. Ann N Y Acad Sci. 2006;947:42-55.
24.
Fager G.Thrombin and proliferation of vascular smooth muscle cells. Circ Res. 1995;77(4):645-650.
25.
Force T., Bonventre JVGrowth factors and mitogen-activated protein kinases. Hypertension . 1998;31(1 pt 2):152-161.
26.
Zhang YZ, Gao PJ, Wang XY, et al. The inhibitory mechanisms of amlodipine in human vascular smooth muscle cell proliferation. Hypertens Res. 2000;23(4):403-406.
27.
Cowley S., Paterson H., Kemp P., et al. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell. 1994;77(6): 841-852.
28.
Molloy CJ, Pawlowski JE, Taylor DS, et al. Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for an obligate autocrine mechanism promoting cell proliferation induced by G-protein-coupled receptor agonist. J Clin Invest. 1996;97(5):1173-1183.
29.
Pouyssegur J., Seuwen K.Transmembrane receptors and intracellular pathways that control cell proliferation. Annu Rev Physiol . 1992;54:195-210.
30.
Taha C., Klip A.The insulin signaling pathway. J Membr Biol. 1999;169(1):1-12.
31.
Myers MG Jr , Backer JM, Sun XJIRS-1 activates phosphatidylinositol 3′-kinase by associating with src homology 2 domains of p85. Proc Natl Acad Sci USA. 1992;89(21):10350-10354.
32.
Burgering BM , Coffer PJProtein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 1995;376(6541):599-602.
33.
Boulton TG, Nye SH, Robbins DJ, et al. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell. 1991; 65(4):663-675.
34.
Cusi K., Maezono K., Osman A., et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest . 2000;105(3):311-320.
35.
Montagnani M., Golovchenko I., Kim I., et al. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem. 2002;277(3):1794-1799.
36.
Hayashi K., Saga H., Chimori Y., et al. Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase . J Biol Chem. 1998;273(44):28860-28867.
37.
Isenovic ER , Meng Y., Jamali N., et al. Ang II attenuates IGF-1-stimulated Na+, K(+)-ATPase activity via PI3K/Akt pathway in vascular smooth muscle cells . Int J Mol Med. 2004;13(6): 915-922.
38.
Geng YJ, Libby P.Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol. 2002; 22(9):1370-1380.
39.
Shepherd PR , Nave BT, Rincon J., et al. Involvement of phosphoinositide 3-kinase in insulin stimulation of MAP-kinase and phosphorylation of protein kinase-B in human skeletal muscle: implications for glucose metabolism. Diabetologia. 1997; 40(10):1172-1177.
40.
McNamara CA , Sarembock IJ, Bachhuber BG, et al. Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis. Semin Thromb Hemost. 1996; 22(2):139-144.
41.
Zwick E., Hackel PO, Prenzel N., et al. The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol Sci. 1999;20(10):408-412.
42.
Prenzel N., Zwick E., Daub H., et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 1999;402(6764):884-888.
43.
Kalmes A., Vesti BR, Daum G., et al. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ Res. 2000; 87(2):92-98.
44.
Bobe R., Yin X., Roussanne MC, et al. Evidence for ERK1/2 activation by thrombin that is independent of EGFR transactivation. Am J Physiol Heart Circ Physiol. 2003;285(2):H745-H754.
45.
Daub H., Weiss FU, Wallasch C., et al. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature. 1996;379(6565):557-560.
46.
Wang H., Ubl JJ, Stricker R., et al. Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways. Am J Physiol Cell Physiol . 2002;283(5):C1351-C1364.
47.
Eguchi S., Numaguchi K., Iwasaki H., et al. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem. 1998; 273(15):8890-8896.
48.
Ginnan R., Singer HACaM kinase II-dependent activation of tyrosine kinases and ERK1/2 in vascular smooth muscle. Am J Physiol. 2002;282(4):C754-C761.
49.
Zwick E., Wallasch C., Daub H., et al. Distinct calcium-dependent pathways of epidermal growth factor receptor transactivation and PYK2 tyrosine phosphorylation in PC12 cells. J Biol Chem. 1999; 274(30):20989-20996.
50.
Chen YH, Pouyssegur J., Courtneidge SA, et al. Activation of Src family kinase activity by the G protein-coupled thrombin receptor in growth-responsive fibroblasts. J Biol Chem. 1994;269(44): 27372-27377.
51.
Schieffer B. , Drexler H., Ling BN, et al. G protein-coupled receptors control vascular smooth muscle cell proliferation via pp60c-src and p21ras. Am J Physiol. 1997;272(6 pt 1):C2019-C2030.
52.
Vaingankar SM, Martins-Green M.Thrombin activation of the 9E3/CEF4 chemokine involves tyrosine kinases including c-src and the epidermal growth factor receptor. J Biol Chem. 1998; 273(9):5226-5234.
53.
Blaukat A., Ivankovic-Dikic I., Gronroos E., et al. Adaptor proteins Grb2 and Crk couple Pyk2 with activation of specific mitogen-activated protein kinase cascades. J Biol Chem. 1999;274(21): 14893-14901.
54.
Dikic I., Tokiwa G., Lev S., et al. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature. 1996;383(6600):547-550.
55.
Kanda Y., Mizuno K., Kuroki Y., et al. Thrombin-induced p38 mitogen-activated protein kinase activation is mediated by epidermal growth factor receptor transactivation pathway. Br J Pharmacol. 2001;132(8):1657-1664.
56.
Ishida M., Ishida T., Thomas SM, et al. Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells. Circ Res. 1998;82(1):7-12.
57.
Ishida T., Ishida M., Suero J., et al. Agonist-stimulated cytoskeletal reorganization and signal transduction at focal adhesions in vascular smooth muscle cells require c-Src. J Clin Invest. 1999; 103(6):789-797.
58.
Touyz RM, Wu XH, He G., et al. Role of c-Src in the regulation of vascular contraction and Ca2+ signaling by angiotensin II in human vascular smooth muscle cells. J Hypertens. 2001;19(3): 441-449.
59.
Ward CW, Gough KH, Rashke M., et al. Systematic mapping of potential binding sites for Shc and Grb2 SH2 domains on insulin receptor substrate-1 and the receptors for insulin, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor. J Biol Chem. 1996;271(10):5603-5609.
60.
Coffer PJ, Kruijer W.EGF receptor deletions define a region specifically mediating STAT transcription factor activation. Biochem Biophys Res Commun. 1995;210(1):74-81.
61.
Helin K., Beguinot L.Internalization and down-regulation of the human epidermal growth factor receptor are regulated by the carboxyl-terminal tyrosines. J Biol Chem . 1991;266(13):8363-8368.
62.
Keyse SMProtein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol. 2000; 12(2):186-192.
63.
Yu Z., Ahmad S., Schwartz JL, Banville D., Shen SHProtein-tyrosine phosphatase SHP2 is positively linked to proteinase-activated receptor 2-mediated mitogenic pathway. J Biol Chem. 1997;272(11):7519-7524.
64.
Maloney JA, Tsygankova OM, Yang L., et al. Activation of ERK by Ca2+ store depletion in rat liver epithelial cells. Am J Physiol. 1999;276(1 pt 1):C221-C230.
